Robotic surgery at distance program
Part of Cancer, Digestive system, Kidney & urinary clinical trials.
This study tests whether remote robotic surgery is safe and effective for people having robot-assisted operations. It may help expand access to specialized surgical care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be in good general health (classified as ASA I or II).
- You must not have major health problems (measured by the Charlson Comorbidity Index).
- You must not have had major abdominal surgery in the past.
- You must be scheduled for an elective robot-assisted surgery.
- You must be able to understand and agree to the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new robotic system that lets surgeons perform laparoscopic surgery from a distance. It's for people with certain cancers needing surgery on the kidney, prostate, stomach, colon, liver, spleen, uterus, or lung.
This trial tests a robotic, top-down approach to remove certain rectal tumors using an intersphincteric resection (a surgery that preserves bowel control as much as possible). It may help some people with stage I–III rectal cancer avoid a bigger operation and improve outcomes compared with standard surgical methods.
This trial uses a robotic system to assist surgeons during chest and belly surgeries. It aims to see if the robot is safe and effective for procedures like hernia repair, gallbladder removal, or hysterectomy.
This study collects health information from men who have had robotic surgery for prostate cancer. It aims to learn more about the outcomes of this surgery to help improve future care.
This study looks at a robotic prostate operation that aims to remove only the affected side while keeping the urethra (the tube for urination) to help preserve urinary function. It’s for people with low- to intermediate-risk, one-sided prostate cancer and no spread to lymph nodes, bones, or other organs.
This trial is looking at whether a new force-feedback feature in the da Vinci robotic system helps surgeons learn and operate more safely when removing the prostate for prostate cancer.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.